How an individual responds to side effects, especially during early exposure, provides insight into whether a medication could be continued safely
Todays Guest Co-Host Links: Watch us on YouTube: Timestamped Show Notes: 06:30 Its just crazy how much money theyre making
For us as clinicians, the 2035 projections map directly onto the chronic disease burden we'll be managingmore diabetes, more cardiovascular disease, more musculoskeletal disease, more Alzheimer's, and higher costs across the board
Mistake 4: No temperature verification Without a thermometer strip, you are guessing
There is no clinical data supporting split-dose semaglutide administration, and the FDA-approved protocols call for a single weekly injection
Patients and clinicians should be aware that reflux-type symptoms are biologically plausible and have been reported in trial settings for this drug class, even if a definitive causal link has not been formally established for retatrutide specifically